PKM and neoplasm: Additionally, Bone Morphogenetic Protein 4 (BMP4) directly binds to the PKM promoter via SMAD5, upregulating PKM2 expression and enhancing glycolytic flux, thereby promoting glucose metabolism reprogramming and tumor progression (44).